China SXT Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $23.1M
Liabilities Breakdown FY2024
Total Liabilities: $9.2M
Asset Breakdown
Total Assets: $23.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $12.1M | 52.2% |
| Accounts Receivable | $1.3M | 5.7% |
| Inventory | $794.9K | 3.4% |
| Property, Plant & Equipment | $328.8K | 1.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $19.1K | 0.1% |
| Other Assets | $8.6M | 37.2% |
Liabilities Breakdown
Total Liabilities: $9.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.3M | 13.9% |
| Long-Term Debt | $117.1K | 1.3% |
| Other Liabilities | $7.8M | 84.8% |